This review, which assessed the use of optical coherence tomography for diagnosing macular oedema attributable to diabetic retinopathy, concluded that optical coherence tomography performs well in comparison with fundus stereophotography or biomicroscopy. The authors' rather optimistic conclusions are, nevertheless, likely to be reliable.
Study selection
Studies of diabetic participants with clinically significant macular oedema, according to Early Treatment of Diabetic Retinopathy Study criteria, were eligible for inclusion. Eligible studies also had to use OCT as an index test (either low or high resolution) and stereoscopic fundus photography, or contact lens or non contact lens biomicroscopy of the fundus, as the reference test.
The type of gold standard used in the included studies varied, and included stereophotography, contact lens or non contact lens biomicroscopy, and a combination of these. Nine studies used low resolution OCT and 6 studies used high resolution OCT. Most of the studies included participants with various levels of diabetic retinopathy; several studies used healthy participants in the control groups. The main outcomes reported were the sensitivity and specificity.
Two reviewers independently selected studies for inclusion, with any disagreements resolved by discussion.
Assessment of study quality
Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) checklist, which uses 14 criteria. Additional criteria, such as use of a sample size calculation, were also used.
Two reviewers independently assessed study quality, with any disagreements being resolved by a third reviewer.
Data extraction
Outcome data were extracted for each study. The sensitivity, specificity, positive and negative likelihood ratios (LRs), and diagnostic odds ratios (DORs) were calculated, along with 95% confidence intervals (CIs), when data were available to do so.
The authors did not state how the data were extracted for the review, or how many reviewers performed the data extraction.
Results of the review
Fifteen studies (n=1,321) were included in the review, of which 11 were prospective cohort studies (n=912), two were retrospective cohort studies (n=150) and one was a retrospective case-control study (n=70); it was unclear whether or not the remaining study (n=189) was prospective in design.
Study quality was generally good, although the reporting and handling of uninterpretable test results was unclear or poorly reported in the majority of studies. No studies reported the use of a sample size calculation.
Sensitivity and specificity data could only be extracted from 6 studies. In five of these studies, central retinal thickness cut-offs between 230 and 300 μm were used to define abnormal OCT results and considered the central type of clinically significant macular oedema only. The expected operating point on the summary ROC corresponded to a sensitivity of 0.79 (5 studies; 95% CI: 0.71, 0.86) and a specificity of 0.88 (95% CI: 0.80, 0.93), with a positive LR of 6.5 (95% CI: 4.0, 10.7) and a negative LR of 0.24 (95% CI: 0.17, 0.32). No statistically significant heterogeneity was found between the pooled cohort studies. Further results were reported.
